Delphine Hequet is an expert in Oncology at Institut Curie (France). Delphine Hequet has authored 91 publications, the most recent in 2025, and is an investigator in 4 clinical trials. SLR score: 414 (community average: 125). How the SLR is computed.

LeadR Profile

Delphine Hequet Institut Curie France
414 ScienceLeadR Reputation 414
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2009 - 2025

Source: PubMed

Institut Curie

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 91

Citations

Citations: 2 062 1st author: 27 Last author: 21 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Les coûts environnementaux liés aux transports dans l’évaluation économique d’un parcours de soins : application à la prise en charge du cancer du sein dans l’ouest francilien
OpenAlex W4280647608 — neoplasms
Rev Econ Reg Urbaine20250
Prevalence of sexual dysfunction after breast cancer compared to controls, a study from CONSTANCES cohort.
PMID 37278872 — breast neoplasms, pain, neoplasms, sexuality, breast, multivariate analysis, prevalence, sex, risk factors, survivorship, history, demography
J Cancer Surviv20238
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.
PMID 37409516 — research design, epidermal growth factor, growth, breast neoplasms, neoplasms, decision making, drug therapy, hormones, chemotherapy, adjuvant, receptors, growth factor, breast, chemotherapy
Cancer Med20232
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis.
PMID 37427133 — research design, breast neoplasms, cost savings, neoplasms, drug therapy, chemotherapy, adjuvant, breast, therapeutics, chemotherapy
Front Oncol20234
Psychometric properties of the French Hot Flash Related Daily Interference Scale (HFRDIS).
PMID 35940182 — breast neoplasms, neoplasms, signs and symptoms, hot flashes, breast, psychometrics
Climacteric20225

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Director: 2

By phase:

N/A 4

By status:

Completed 4

By type:

Observational 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map